ÎÞÓǶÌÊÓƵ

Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

v3.23.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Total
Common Stock
Additional Paid-In Capital
Treasury Stock
Accumulated Deficit
Beginning balance (in shares) at Apr. 30, 2021 Ìý 25,066,297 Ìý Ìý Ìý
Beginning balance at Apr. 30, 2021 $ 49,090,474 $ 25,067 $ 109,040,824 $ (1,817,414) $ (58,158,003)
Increase (Decrease) in Stockholders' Equity [Roll Forward] Ìý Ìý Ìý Ìý Ìý
Stock-based compensation 1,965,567 Ìý 1,965,567 Ìý Ìý
Common stock issued for vested restricted stock units (in shares) Ìý 73,708 Ìý Ìý Ìý
Common stock issued for vested restricted stock units 0 $ 74 (74) Ìý Ìý
Common stock issued for stock options exercised for cash (in shares) Ìý 58,419 Ìý Ìý Ìý
Common stock issued for stock options exercised for cash 191,034 $ 58 190,976 Ìý Ìý
Common stock issued for cashless stock options exercised (in shares) Ìý 30,156 Ìý Ìý Ìý
Common stock issued for cashless stock options exercised 0 $ 30 (30) Ìý Ìý
Amortization of warrant based cost 43,708 Ìý 43,708 Ìý Ìý
Warrants issued for deferred financing costs related to Credit Facility 137,500 Ìý 137,500 Ìý Ìý
Net loss (7,457,143) Ìý Ìý Ìý (7,457,143)
Ending balance (in shares) at Jan. 31, 2022 Ìý 25,228,580 Ìý Ìý Ìý
Ending balance at Jan. 31, 2022 43,971,140 $ 25,229 111,378,471 (1,817,414) (65,615,146)
Beginning balance (in shares) at Oct. 31, 2021 Ìý 25,148,194 Ìý Ìý Ìý
Beginning balance at Oct. 31, 2021 46,853,315 $ 25,149 110,526,729 (1,817,414) (61,881,149)
Increase (Decrease) in Stockholders' Equity [Roll Forward] Ìý Ìý Ìý Ìý Ìý
Stock-based compensation 700,697 Ìý 700,697 Ìý Ìý
Common stock issued for vested restricted stock units (in shares) Ìý 38,719 Ìý Ìý Ìý
Common stock issued for vested restricted stock units 0 $ 39 (39) Ìý Ìý
Common stock issued for stock options exercised for cash (in shares) Ìý 41,667 Ìý Ìý Ìý
Common stock issued for stock options exercised for cash 135,000 $ 41 134,959 Ìý Ìý
Amortization of warrant based cost 16,125 Ìý 16,125 Ìý Ìý
Net loss (3,733,997) Ìý Ìý Ìý (3,733,997)
Ending balance (in shares) at Jan. 31, 2022 Ìý 25,228,580 Ìý Ìý Ìý
Ending balance at Jan. 31, 2022 $ 43,971,140 $ 25,229 111,378,471 (1,817,414) (65,615,146)
Beginning balance (in shares) at Apr. 30, 2022 25,202,278 25,357,764 Ìý Ìý Ìý
Beginning balance at Apr. 30, 2022 $ 42,545,724 $ 25,358 112,081,564 (1,817,414) (67,743,784)
Increase (Decrease) in Stockholders' Equity [Roll Forward] Ìý Ìý Ìý Ìý Ìý
Stock-based compensation 899,176 Ìý 899,176 Ìý Ìý
Common stock issued for vested restricted stock units (in shares) Ìý 192,233 Ìý Ìý Ìý
Common stock issued for vested restricted stock units 0 $ 192 (192) Ìý Ìý
Common stock issued for services (in shares) Ìý 25,000 Ìý Ìý Ìý
Common stock issued for services 24,500 $ 25 24,475 Ìý Ìý
Common stock issued for equity raise, net of underwriter costs (in shares) Ìý 11,840 Ìý Ìý Ìý
Common stock issued for equity raise, net of underwriter costs 9,535 $ 12 9,523 Ìý Ìý
Warrants issued for deferred financing costs related to Credit Facility 21,000 Ìý 21,000 Ìý Ìý
Net loss $ (7,563,651) Ìý Ìý Ìý (7,563,651)
Ending balance (in shares) at Jan. 31, 2023 25,431,351 25,586,837 Ìý Ìý Ìý
Ending balance at Jan. 31, 2023 $ 35,936,284 $ 25,587 113,035,546 (1,817,414) (75,307,435)
Beginning balance (in shares) at Oct. 31, 2022 Ìý 25,460,849 Ìý Ìý Ìý
Beginning balance at Oct. 31, 2022 37,089,814 $ 25,461 112,634,162 (1,817,414) (73,752,395)
Increase (Decrease) in Stockholders' Equity [Roll Forward] Ìý Ìý Ìý Ìý Ìý
Stock-based compensation 394,510 Ìý 394,510 Ìý Ìý
Common stock issued for vested restricted stock units (in shares) Ìý 125,988 Ìý Ìý Ìý
Common stock issued for vested restricted stock units 0 $ 126 (126) Ìý Ìý
Amortization of warrant based cost 7,000 Ìý 7,000 Ìý Ìý
Net loss $ (1,555,040) Ìý Ìý Ìý (1,555,040)
Ending balance (in shares) at Jan. 31, 2023 25,431,351 25,586,837 Ìý Ìý Ìý
Ending balance at Jan. 31, 2023 $ 35,936,284 $ 25,587 $ 113,035,546 $ (1,817,414) $ (75,307,435)